Publications by authors named "H Ahmeti"

Somatosensory evoked potentials are frequently acquired by stimulation of the median or tibial nerves (mSEPs and tSEPs) for intraoperative monitoring of sensory pathways. Due to their low amplitudes it is common practice to average 200 or more sweeps to discern the evoked potentials from the background EEG. The aim of this study was to investigate if an algorithm designed to determine the lowest sweep count needed to obtain reproducible evoked potentials in each patient significantly reduces the median necessary sweep count to under 200.

View Article and Find Full Text PDF

Purpose: The introduction of molecular markers in to the diagnosis of gliomas has changed the therapeutic approach to this tumors. The aim of this study was to examine the impact of surgery on anaplastic astrocytomas (AA), which has not previously been fully elucidated.

Methods: This was a retrospective study involving a total of 143 patients who underwent surgery for primary AA in our department between 1995 and 2020.

View Article and Find Full Text PDF

Glioblastomas (GBMs) are characterized by high heterogeneity, involving diverse cell types, including those with stem-like features contributing to GBM's malignancy. Moreover, metabolic alterations promote growth and therapeutic resistance of GBM. Depending on the metabolic state, antimetabolic treatments could be an effective strategy.

View Article and Find Full Text PDF

Background: Convexity meningiomas (CM) can be successfully treated with neurosurgery. However, clinical complications due to CM have been reported. Moreover, systematic investigations of CM with respect to all relevant clinical factors are currently lacking.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied how a type of brain cancer called glioblastoma (GBM) can become dormant and how a drug called temozolomide (TMZ) affects this process.
  • They found specific genes that change their activity during this dormancy, including CCRL1, SLFN13, SKI, Cables1, and DCHS1, which they looked at more closely.
  • The study showed that these genes are connected to the cancer's stemness, meaning they help the cancer cells stay alive and grow, and stopping one of these genes (SKI) made the drug work better against the cancer.
View Article and Find Full Text PDF